The abstract is read at the publisher; the summary is JClub's.
TAO-TMS personalized connectivity-guided accelerated iTBS produced 65% immediate response in a naturalistic Asian treatment-resistant depression sample, with 50% at 1 month and 31% at 3 months.
- Why it matters: Naturalistic TRD patients often have complex comorbidities excluded from prior connectivity-guided iTBS trials, leaving uncertainty about real-world feasibility and clinical signals.
- What they did: In an open-label single-arm proof-of-concept study, 21 enrolled participants received 50 iTBS sessions over 5 days; response required ≥50% reduction on the Montgomery-Asberg Depression Rating Scale, with post hoc electric-field modeling and connectivity analyses.
- The result: Among participants with available data, 70% responded within 4 weeks, and 83% in a subgroup meeting typical trial eligibility (N = 12); TAO-TMS was feasible, well tolerated, and showed attention-network targeting.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.